论文部分内容阅读
阿米卡辛(Amikacin)为卡那霉素的半合成衍生物,体外试验证实为广谱抗固紫染色阴性杆菌药物,但其不同于卡那霉素之处为对绿脓杆菌、多种肠杆菌和耐庆大霉素的假单胞菌也有效。作者用阿米卡辛治疗18个病人共19次,年龄在19岁～79岁,除2例外均有严重的内科或外科疾患。感染部位:泌尿道5例,肺部4例,软组织6例,骨2例,胸膜腔3例,胆道2例。阿米卡辛治疗前感染存时在
Amikacin, a semisynthetic derivative of kanamycin, has been shown to be a broad-spectrum anti-violet-violet-negative bacilli drug in vitro but differs from kanamycin in its resistance to Pseudomonas aeruginosa, Enterobacteriaceae and gentamicin-resistant Pseudomonas are also effective. The authors treated 18 patients with amikacin a total of 19 times, aged 19 to 79 years old, with the exception of two cases have serious medical or surgical conditions. Infected parts: 5 cases of urinary tract, 4 cases of lung, 6 cases of soft tissue, 2 cases of bone, pleural cavity in 3 cases, biliary tract in 2 cases. Amikacin pre-treatment save the deposit at